The Novel Long Intergenic Noncoding Rna Ucc Promotes Colorectal Cancer Progression by Sponging Mir-143

Feng-Ting Huang,Wen-Ying Chen,Zhi-Qiang Gu,Yan-Yan Zhuang,Chu-Qiang Li,Ling-Yun Wang,Juan-Fei Peng,Zhe Zhu,Xin Luo,Yuan-Hua Li,He-Rui Yao,Shi-Neng Zhang
DOI: https://doi.org/10.1038/cddis.2017.191
2017-01-01
Cell Death and Disease
Abstract:The human genome contains thousands of long intergenic noncoding RNAs (lincRNAs). However, the functional roles of these transcripts and the mechanisms responsible for their deregulation in colorectal cancer (CRC) remain elusive. A novel lincRNA termed upregulated in CRC (UCC) was found to be highly expressed in human CRC tissues and cell lines. UCC levels correlated with lymph node metastasis, Dukes' stage, and patient outcomes. In SW480 and SW620 cells, knockdown of UCC inhibited proliferation, invasion, and cell cycle progression and induced apoptosis in vitro. Xenograft tumors grown from UCC-silenced SW620 cells had smaller mean volumes and formed more slowly than xenograft tumors grown from control cells. Inversely, overexpression of UCC in HCT116 promoted cell growth and invasion in vitro. Bioinformatics analysis, dual-luciferase reporter assays, and RNA immunoprecipitation assays showed that miR-143 can interact with UCC, and we found that UCC expression inversely correlates with miR-143 expression in CRC specimens. Moreover, mechanistic investigations showed that UCC may act as an endogenous sponge by competing for miR-143, thereby regulating the targets of this miRNA. Our results suggest that UCC and miR-143 may be promising molecular targets for CRC therapy.
What problem does this paper attempt to address?